Avrobio Inc (AVRO)
1.20
0.00 (0.00%)
USD |
NASDAQ |
Apr 23, 16:00
1.20
0.00 (0.00%)
After-Hours: 16:53
Avrobio Cash from Operations (TTM): -63.19M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -63.19M |
September 30, 2023 | -78.83M |
June 30, 2023 | -75.02M |
March 31, 2023 | -89.48M |
December 31, 2022 | -97.21M |
September 30, 2022 | -99.43M |
June 30, 2022 | -107.84M |
March 31, 2022 | -98.70M |
December 31, 2021 | -98.02M |
September 30, 2021 | -102.62M |
June 30, 2021 | -102.66M |
March 31, 2021 | -103.71M |
December 31, 2020 | -98.80M |
Date | Value |
---|---|
September 30, 2020 | -86.90M |
June 30, 2020 | -75.42M |
March 31, 2020 | -72.36M |
December 31, 2019 | -67.67M |
September 30, 2019 | -60.52M |
June 30, 2019 | -59.12M |
March 31, 2019 | -49.41M |
December 31, 2018 | -37.65M |
September 30, 2018 | -35.04M |
June 30, 2018 | -26.15M |
March 31, 2018 | -20.35M |
December 31, 2017 | -16.38M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-107.84M
Minimum
Jun 2022
-59.12M
Maximum
Jun 2019
-86.18M
Average
-89.48M
Median
Mar 2023
Cash from Operations (TTM) Benchmarks
Axonics Inc | -2.016M |
Catalent Inc | 174.00M |
AIM ImmunoTech Inc | -21.27M |
Protalix BioTherapeutics Inc | -1.318M |
Armata Pharmaceuticals Inc | -47.42M |